ICYMI: PhRMA COO Lori Reilly Esq. speaks with Jacob Van Naarden about the future of cancer research

Our health care ecosystem has made tremendous progress in the fight against cancer, with the cancer death rate falling 32% from its peak in 1991. On November 3, PhRMA sponsored The Atlantic ’s People v. Cancer event, hosting the sessionPhRMA Presents: The Future of Fighting Cancer. PhRMA ’s COO Lori Reilly, Esq., spoke with Eli Lilly and Company’s Jacob Van Naarden, CEO of Loxo@Lilly, about the incredible advancements made in cancer treatment.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Research and Development Cancer Source Type: news